vs

Side-by-side financial comparison of ICON PLC (ICLR) and VEON Ltd. (VEON). Click either name above to swap in a different company.

ICON PLC is the larger business by last-quarter revenue ($2.0B vs $1.1B, roughly 1.9× VEON Ltd.). VEON Ltd. runs the higher net margin — 55.9% vs 0.1%, a 55.8% gap on every dollar of revenue. On growth, VEON Ltd. posted the faster year-over-year revenue change (5.8% vs 0.6%).

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

VEON Ltd., also known as VEON Group, is a multinational telecommunication and digital services company. Headquartered in Dubai, the company is publicly traded on the U.S.-based NASDAQ stock exchange. VEON operates in six markets in Europe and Asia, including Bangladesh, Kazakhstan, Kyrgyzstan, Pakistan, Ukraine and Uzbekistan. Specific brands include Banglalink in Bangladesh, Jazz in Pakistan, Kyivstar in Ukraine, and units operating in Kazakhstan, Kyrgyzstan, and Uzbekistan under the Beeline...

ICLR vs VEON — Head-to-Head

Bigger by revenue
ICLR
ICLR
1.9× larger
ICLR
$2.0B
$1.1B
VEON
Growing faster (revenue YoY)
VEON
VEON
+5.2% gap
VEON
5.8%
0.6%
ICLR
Higher net margin
VEON
VEON
55.8% more per $
VEON
55.9%
0.1%
ICLR

Income Statement — Q3 FY2025 vs Q2 FY2025

Metric
ICLR
ICLR
VEON
VEON
Revenue
$2.0B
$1.1B
Net Profit
$2.4M
$608.0M
Gross Margin
Operating Margin
4.2%
75.4%
Net Margin
0.1%
55.9%
Revenue YoY
0.6%
5.8%
Net Profit YoY
-98.8%
583.1%
EPS (diluted)
$0.03
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICLR
ICLR
VEON
VEON
Q3 25
$2.0B
Q2 25
$2.0B
$1.1B
Q1 25
$2.0B
Q3 24
$2.0B
Q2 24
$2.1B
$1.0B
Q1 24
$2.1B
Q3 23
$2.1B
Q2 23
$2.0B
$916.0M
Net Profit
ICLR
ICLR
VEON
VEON
Q3 25
$2.4M
Q2 25
$183.0M
$608.0M
Q1 25
$154.2M
Q3 24
$197.1M
Q2 24
$146.9M
$89.0M
Q1 24
$187.4M
Q3 23
$163.7M
Q2 23
$115.6M
$271.0M
Operating Margin
ICLR
ICLR
VEON
VEON
Q3 25
4.2%
Q2 25
10.4%
75.4%
Q1 25
11.0%
Q3 24
14.1%
Q2 24
10.8%
27.1%
Q1 24
13.7%
Q3 23
12.9%
Q2 23
10.4%
26.4%
Net Margin
ICLR
ICLR
VEON
VEON
Q3 25
0.1%
Q2 25
9.1%
55.9%
Q1 25
7.7%
Q3 24
9.7%
Q2 24
6.9%
8.7%
Q1 24
9.0%
Q3 23
8.0%
Q2 23
5.7%
29.6%
EPS (diluted)
ICLR
ICLR
VEON
VEON
Q3 25
$0.03
Q2 25
$2.30
$0.34
Q1 25
$1.90
Q3 24
$2.36
Q2 24
$1.76
$0.04
Q1 24
$2.25
Q3 23
$1.97
Q2 23
$1.40
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICLR
ICLR
VEON
VEON
Cash + ST InvestmentsLiquidity on hand
$468.9M
$1.3B
Total DebtLower is stronger
Stockholders' EquityBook value
$9.3B
$1.5B
Total Assets
$16.5B
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICLR
ICLR
VEON
VEON
Q3 25
$468.9M
Q2 25
$390.4M
$1.3B
Q1 25
$526.7M
Q3 24
$695.5M
Q2 24
$506.6M
$862.0M
Q1 24
$396.1M
Q3 23
$313.1M
Q2 23
$270.2M
$2.5B
Stockholders' Equity
ICLR
ICLR
VEON
VEON
Q3 25
$9.3B
Q2 25
$9.6B
$1.5B
Q1 25
$9.5B
Q3 24
$9.8B
Q2 24
$9.6B
$1.1B
Q1 24
$9.4B
Q3 23
$9.0B
Q2 23
$8.8B
$988.0M
Total Assets
ICLR
ICLR
VEON
VEON
Q3 25
$16.5B
Q2 25
$16.6B
$8.5B
Q1 25
$16.7B
Q3 24
$17.2B
Q2 24
$17.0B
$7.3B
Q1 24
$17.0B
Q3 23
$17.0B
Q2 23
$17.1B
$13.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICLR
ICLR
VEON
VEON
Operating Cash FlowLast quarter
$387.6M
Free Cash FlowOCF − Capex
$333.9M
FCF MarginFCF / Revenue
16.3%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
164.59×
TTM Free Cash FlowTrailing 4 quarters
$1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICLR
ICLR
VEON
VEON
Q3 25
$387.6M
Q2 25
$146.2M
Q1 25
$268.2M
Q3 24
$402.7M
Q2 24
$218.6M
Q1 24
$327.1M
Q3 23
$341.5M
Q2 23
$203.9M
Free Cash Flow
ICLR
ICLR
VEON
VEON
Q3 25
$333.9M
Q2 25
$113.9M
Q1 25
$239.3M
Q3 24
$359.3M
Q2 24
$182.3M
Q1 24
$299.9M
Q3 23
$312.4M
Q2 23
$171.7M
FCF Margin
ICLR
ICLR
VEON
VEON
Q3 25
16.3%
Q2 25
5.6%
Q1 25
12.0%
Q3 24
17.7%
Q2 24
8.6%
Q1 24
14.3%
Q3 23
15.2%
Q2 23
8.5%
Capex Intensity
ICLR
ICLR
VEON
VEON
Q3 25
2.6%
Q2 25
1.6%
Q1 25
1.4%
Q3 24
2.1%
Q2 24
1.7%
Q1 24
1.3%
Q3 23
1.4%
Q2 23
1.6%
Cash Conversion
ICLR
ICLR
VEON
VEON
Q3 25
164.59×
Q2 25
0.80×
Q1 25
1.74×
Q3 24
2.04×
Q2 24
1.49×
Q1 24
1.74×
Q3 23
2.09×
Q2 23
1.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ICLR
ICLR

Other Customers$681.3M33%
Clients1125$549.4M27%
Clients15$503.3M25%
Clients610$308.8M15%

VEON
VEON

Segment breakdown not available.

Related Comparisons